[1]
Couto, M. do R., Pinto, D., Oliveira, J., Monteiro, A., Pereira, D., Medeiros, R. and Rodrigues, H. 2011. The predictive and monitoring value of serum HER2/NEU in breast cancer under trastuzumab therapy. Acta Médica Portuguesa. 24, 1 (Feb. 2011), 5–16. DOI:https://doi.org/10.20344/amp.349.